Atria Wealth Solutions Inc. Decreases Stake in Direxion HCM Tactical Enhanced U.S. ETF $HCMT

Atria Wealth Solutions Inc. cut its holdings in Direxion HCM Tactical Enhanced U.S. ETF (NYSEARCA:HCMTFree Report) by 69.9% during the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 13,641 shares of the company’s stock after selling 31,613 shares during the quarter. Atria Wealth Solutions Inc.’s holdings in Direxion HCM Tactical Enhanced U.S. ETF were worth $445,000 as of its most recent SEC filing.

Several other institutional investors have also modified their holdings of HCMT. Howard Capital Management Inc. lifted its stake in Direxion HCM Tactical Enhanced U.S. ETF by 2.5% in the 1st quarter. Howard Capital Management Inc. now owns 8,459,568 shares of the company’s stock valued at $255,564,000 after buying an additional 202,551 shares in the last quarter. Efficient Advisors LLC acquired a new stake in Direxion HCM Tactical Enhanced U.S. ETF in the 1st quarter valued at $22,260,000. Discipline Wealth Solutions LLC increased its holdings in Direxion HCM Tactical Enhanced U.S. ETF by 52.1% in the 2nd quarter. Discipline Wealth Solutions LLC now owns 270,783 shares of the company’s stock valued at $8,822,000 after purchasing an additional 92,740 shares in the last quarter. Envestnet Asset Management Inc. increased its holdings in Direxion HCM Tactical Enhanced U.S. ETF by 32.4% in the 1st quarter. Envestnet Asset Management Inc. now owns 170,881 shares of the company’s stock valued at $5,162,000 after purchasing an additional 41,778 shares in the last quarter. Finally, CPR Investments Inc. increased its holdings in Direxion HCM Tactical Enhanced U.S. ETF by 57.2% in the 2nd quarter. CPR Investments Inc. now owns 170,496 shares of the company’s stock valued at $5,555,000 after purchasing an additional 62,034 shares in the last quarter.

Direxion HCM Tactical Enhanced U.S. ETF Trading Up 1.0%

Shares of NYSEARCA HCMT opened at $37.55 on Monday. Direxion HCM Tactical Enhanced U.S. ETF has a 12-month low of $24.58 and a 12-month high of $39.52. The company has a market cap of $565.88 million, a P/E ratio of 21.26 and a beta of 1.80. The stock has a fifty day moving average price of $36.07 and a 200 day moving average price of $32.09.

Direxion HCM Tactical Enhanced U.S. ETF Profile

(Free Report)

The Direxion HCM Tactical Enhanced US ETF (HCMT) is an exchange-traded fund that mostly invests in total market equity. The fund is an actively managed fund-of-funds that toggles between a 200% leveraged US equity position and a 100% investment to cash or cash equivalents based on a proprietary tactical indicator that identifies broad trends in the US equity markets.

Featured Articles

Want to see what other hedge funds are holding HCMT? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Direxion HCM Tactical Enhanced U.S. ETF (NYSEARCA:HCMTFree Report).

Institutional Ownership by Quarter for Direxion HCM Tactical Enhanced U.S. ETF (NYSEARCA:HCMT)

Receive News & Ratings for Direxion HCM Tactical Enhanced U.S. ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Direxion HCM Tactical Enhanced U.S. ETF and related companies with MarketBeat.com's FREE daily email newsletter.